MOAP-1, UBR5 and cisplatin resistance in ovarian cancer.

about

MOAP-1, UBR5 and cisplatin resistance in ovarian cancer.

Item

http://www.wikidata.org/entity/Q53752343

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

MOAP-1, UBR5 and cisplatin resistance in ovarian cancer.

@en

MOAP-1, UBR5 and cisplatin resistance in ovarian cancer.

@nl

type

Item

label

MOAP-1, UBR5 and cisplatin resistance in ovarian cancer.

@en

MOAP-1, UBR5 and cisplatin resistance in ovarian cancer.

@nl

prefLabel

MOAP-1, UBR5 and cisplatin resistance in ovarian cancer.

@en

MOAP-1, UBR5 and cisplatin resistance in ovarian cancer.

@nl

P1476

MOAP-1, UBR5 and cisplatin resistance in ovarian cancer.

@en

P2093

Amber Bradley

http://www.w3.org/2001/XMLSchema#string

Scott T Eblen

http://www.w3.org/2001/XMLSchema#string

P2860

MAP-1, a novel proapoptotic protein containing a BH3-like motif that associates with Bax through its Bcl-2 homology domains

TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes

EDD, the human hyperplastic discs protein, has a role in progesterone receptor coactivation and potential involvement in DNA damage response

The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death

TRIM39 is a MOAP-1-binding protein that stabilizes MOAP-1 through inhibition of its poly-ubiquitination process

Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase

MAP-1 is a mitochondrial effector of Bax.

Inhibition of ubiquitin-mediated degradation of MOAP-1 by apoptotic stimuli promotes Bax function in mitochondria

EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer

EDD mediates DNA damage-induced activation of CHK2

P304

S18-S21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/TCR.2017.02.01

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29607295

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

5878060

http://www.w3.org/2001/XMLSchema#string